Saved in:
| Main Authors: | Hillary S. Hayden, Maria T. Nelson, Sydney E. Ross, Adrian J. Verster, Drake C. Bouzek, Alex Eng, Adam Waalkes, Kelsi Penewit, Benjamin T. Kopp, Christopher Siracusa, Michael J. Rock, Stephen J. Salipante, Lucas R. Hoffman, Don B. Sanders |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1002/ppul.71024 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase‐1 in Children With Cystic Fibrosis
by: Senthilkumar Sankararaman, et al.
Published: (2025)
by: Senthilkumar Sankararaman, et al.
Published: (2025)
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
by: Cindy L. Williams, et al.
Published: (2025)
by: Cindy L. Williams, et al.
Published: (2025)
Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
by: Laurie P. Murray, et al.
Published: (2025)
by: Laurie P. Murray, et al.
Published: (2025)
The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis
by: Leslie Huang, et al.
Published: (2025)
by: Leslie Huang, et al.
Published: (2025)
Infant Lung Function in Cystic Fibrosis: A Real‐World Study
by: Michele Arigliani, et al.
Published: (2025)
by: Michele Arigliani, et al.
Published: (2025)
Utility of Fecal Elastase‐1 in Estimating Exocrine Pancreatic Function in Cystic Fibrosis: A Scoping Review
by: Senthilkumar Sankararaman, et al.
Published: (2026)
by: Senthilkumar Sankararaman, et al.
Published: (2026)
Acceptability of Telehealth Post‐Pandemic Among Clinicians Across the United States Caring for People With Cystic Fibrosis
by: Jaclyn Davis, et al.
Published: (2025)
by: Jaclyn Davis, et al.
Published: (2025)
Risk Factors and Outcomes of Pulmonary Exacerbations in Infants and Young Children With Cystic Fibrosis
by: Aoife Corcoran, et al.
Published: (2025)
by: Aoife Corcoran, et al.
Published: (2025)
Initial Antibiotic Selection Based on Microbiologic History in Pediatric Cystic Fibrosis‐Related Pulmonary Exacerbations
by: Jillian Grapsy, et al.
Published: (2025)
by: Jillian Grapsy, et al.
Published: (2025)
E‐Cigarettes and Cystic Fibrosis—Current Perceptions and Future Directions
by: Maryam Sahibqran, et al.
Published: (2024)
by: Maryam Sahibqran, et al.
Published: (2024)
Pathophysiology of Cystic Fibrosis Liver Disease
by: Vania L. Kasper, et al.
Published: (2024)
by: Vania L. Kasper, et al.
Published: (2024)
Roadmap to Global Cystic Fibrosis Care
by: Samya Z. Nasr, et al.
Published: (2025)
by: Samya Z. Nasr, et al.
Published: (2025)
Cystic Fibrosis Year in Review 2024
by: Adrienne P. Savant
Published: (2025)
by: Adrienne P. Savant
Published: (2025)
A Tale of Two Infants: Off‐Label Use of Elexacaftor/Tezacaftor/Ivacaftor in Early Cystic Fibrosis Treatment
by: Nour K. Kadouh, et al.
Published: (2025)
by: Nour K. Kadouh, et al.
Published: (2025)
The Impact of Cystic Fibrosis‐Related Diabetes on Barriers to Self‐Management
by: Rebecca J. Vitale, et al.
Published: (2026)
by: Rebecca J. Vitale, et al.
Published: (2026)
Anxiety in the Pediatric Cystic Fibrosis Population: Evaluation of a Younger Cohort
by: Jemilla Strode Smith, et al.
Published: (2025)
by: Jemilla Strode Smith, et al.
Published: (2025)
Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
by: Rebecca Gallardo, et al.
Published: (2026)
by: Rebecca Gallardo, et al.
Published: (2026)
Expanding Cystic Fibrosis Registries to the Rest of the World
by: Lutz Naehrlich
Published: (2026)
by: Lutz Naehrlich
Published: (2026)
Peripheral Muscle Function and Body Composition in People With Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A Cross‐Sectional Single‐Centre Study
by: Lauren J. Clayton, et al.
Published: (2025)
by: Lauren J. Clayton, et al.
Published: (2025)
Molecular Methods to Detect and Quantify Fungal Communities in Cystic Fibrosis Airway Specimens
by: Matthew K. Fought, et al.
Published: (2026)
by: Matthew K. Fought, et al.
Published: (2026)
Disparities in Access to Cystic Fibrosis Therapy Across Countries
by: Bulent Karadag
Published: (2026)
by: Bulent Karadag
Published: (2026)
“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
by: Tuğba Şişmanlar Eyüboğlu, et al.
Published: (2026)
by: Tuğba Şişmanlar Eyüboğlu, et al.
Published: (2026)
Exploring Exercise as Airway Clearance in Cystic Fibrosis: A Qualitative Study From the ExACT‐CF Feasibility Trial
by: Emily Taylor, et al.
Published: (2026)
by: Emily Taylor, et al.
Published: (2026)
Induced Sputum: A Valuable Tool for Assessing Cellular and Microbiological Characteristics in Cystic Fibrosis Expectorating Teenagers
by: M. Guedes, et al.
Published: (2025)
by: M. Guedes, et al.
Published: (2025)
The Impact of Attention Deficit Hyperactivity Disorder on Home Spirometry and Other Parameters in People With Cystic Fibrosis
by: Aqeem Azam, et al.
Published: (2025)
by: Aqeem Azam, et al.
Published: (2025)
Plasma Microbial Cell‐Free DNA Metagenomic Next‐Generation Sequencing in People With Cystic Fibrosis
by: Mollie G. Wasserman, et al.
Published: (2024)
by: Mollie G. Wasserman, et al.
Published: (2024)
Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
by: Chelsea Flora, et al.
Published: (2026)
by: Chelsea Flora, et al.
Published: (2026)
Case Report: Alpha‐Gal Diagnosis in an Adolescent With Cystic Fibrosis
by: Sean Coyne, et al.
Published: (2024)
by: Sean Coyne, et al.
Published: (2024)
Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care
by: Brittany A. Wright, et al.
Published: (2025)
by: Brittany A. Wright, et al.
Published: (2025)
Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
by: Emma M. Tillman, et al.
Published: (2025)
by: Emma M. Tillman, et al.
Published: (2025)
Patient‐Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape
by: Suzanne Kroes, et al.
Published: (2026)
by: Suzanne Kroes, et al.
Published: (2026)
Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
by: Charissa W. Kam, et al.
Published: (2024)
by: Charissa W. Kam, et al.
Published: (2024)
Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
by: Elizabeth Clarke, et al.
Published: (2024)
by: Elizabeth Clarke, et al.
Published: (2024)
Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis
by: Lauren N. Kormelink, et al.
Published: (2024)
by: Lauren N. Kormelink, et al.
Published: (2024)
Pica‐Induced Airway Obstruction in Paediatric Cystic Fibrosis: An Unexpected Culprit
by: Anna Šmejkalová, et al.
Published: (2025)
by: Anna Šmejkalová, et al.
Published: (2025)
A Dose of Hope: Successful Tobramycin Desensitization in Pediatric Cystic Fibrosis
by: Isabel G. Wedig, et al.
Published: (2025)
by: Isabel G. Wedig, et al.
Published: (2025)
Knowledge, Attitudes, and Behaviors of Cystic Fibrosis Patients on Reproductive Health in Turkiye
by: Hande Yuce Ozdemir, et al.
Published: (2025)
by: Hande Yuce Ozdemir, et al.
Published: (2025)
Sleep‐Disordered Breathing in Cystic Fibrosis in Low‐ and Middle‐Income Countries
by: Merve Selçuk Balcı, et al.
Published: (2026)
by: Merve Selçuk Balcı, et al.
Published: (2026)
Cystic Fibrosis Care in South Africa: Facing the Challenge of Diversity and Inequality
by: Marco Zampoli, et al.
Published: (2025)
by: Marco Zampoli, et al.
Published: (2025)
Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis
by: Gabriela R. Oates, et al.
Published: (2025)
by: Gabriela R. Oates, et al.
Published: (2025)
Similar Items
-
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fecal Elastase‐1 in Children With Cystic Fibrosis
by: Senthilkumar Sankararaman, et al.
Published: (2025) -
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
by: Cindy L. Williams, et al.
Published: (2025) -
Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
by: Laurie P. Murray, et al.
Published: (2025) -
The Frequency and Potential Implications of HFE Genetic Variants in Children With Cystic Fibrosis
by: Leslie Huang, et al.
Published: (2025) -
Infant Lung Function in Cystic Fibrosis: A Real‐World Study
by: Michele Arigliani, et al.
Published: (2025)